George D. Yancopoulos

2012

In 2012, George D. Yancopoulos earned a total compensation of $81.6M as President, Regeneron Laboratories and Chief Scientific Officer at Regeneron Pharmaceuticals, a 713% increase compared to previous year.

Compensation breakdown

Bonus$1,955,000
Option Awards$21,442,383
Salary$850,000
Stock Awards$57,275,000
Other$29,065
Total$81,551,448

Yancopoulos received $57.3M in stock awards, accounting for 70.23% of the total pay in 2012.

Yancopoulos also received $2M in bonus, $21.4M in option awards, $850K in salary and $29.1K in other compensation.

Overall ranking

Ranking

3

out of 11,218
Percentile100th

George D. Yancopoulos' 2012 compensation ranked 3rd out of 11,218 executive pay records tracked by us this year.

Yancopoulos earned more than 100.0% of all executives tracked by us in 2012.

Ranking in industry group

Industry groupDrugs
Ranking

1

out of 876
Percentile100th

In the industry group of Drugs, Yancopoulos' pay ranked 1st out of 876 executive pay records tracked by us in 2012.

Yancopoulos earned more than 99.9% of executives in this group.

Source: SEC filing on April 21, 2015.

Yancopoulos' colleagues

We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2012.

2012

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2012

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2012

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

2012

Robert Terifay

Regeneron Pharmaceuticals

Senior Vice President, Commercial

News

You may also like